Logo image of ACMR

ACM RESEARCH INC-CLASS A (ACMR) Stock Fundamental Analysis

USA - NASDAQ:ACMR - US00108J1097 - Common Stock

41.56 USD
-1.76 (-4.06%)
Last: 10/3/2025, 8:20:47 PM
41.25 USD
-0.31 (-0.75%)
After Hours: 10/3/2025, 8:20:47 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ACMR. ACMR was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While ACMR is still in line with the averages on profitability rating, there are concerns on its financial health. ACMR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ACMR was profitable.
ACMR had a positive operating cash flow in the past year.
ACMR had positive earnings in each of the past 5 years.
In the past 5 years ACMR reported 4 times negative operating cash flow.
ACMR Yearly Net Income VS EBIT VS OCF VS FCFACMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACMR (5.50%) is better than 72.32% of its industry peers.
ACMR has a better Return On Equity (11.37%) than 75.89% of its industry peers.
ACMR has a Return On Invested Capital of 8.31%. This is in the better half of the industry: ACMR outperforms 76.79% of its industry peers.
ACMR had an Average Return On Invested Capital over the past 3 years of 7.59%. This is below the industry average of 10.93%.
The 3 year average ROIC (7.59%) for ACMR is below the current ROIC(8.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 11.37%
ROIC 8.31%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ACMR Yearly ROA, ROE, ROICACMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

ACMR has a better Profit Margin (13.75%) than 74.11% of its industry peers.
In the last couple of years the Profit Margin of ACMR has declined.
ACMR has a better Operating Margin (17.87%) than 76.79% of its industry peers.
ACMR's Operating Margin has improved in the last couple of years.
The Gross Margin of ACMR (49.40%) is better than 61.61% of its industry peers.
ACMR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.87%
PM (TTM) 13.75%
GM 49.4%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
ACMR Yearly Profit, Operating, Gross MarginsACMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

ACMR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACMR has more shares outstanding
ACMR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACMR is higher compared to a year ago.
ACMR Yearly Shares OutstandingACMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACMR Yearly Total Debt VS Total AssetsACMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.02 indicates that ACMR is not in any danger for bankruptcy at the moment.
ACMR has a Altman-Z score of 3.02. This is comparable to the rest of the industry: ACMR outperforms 45.54% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that ACMR is not too dependend on debt financing.
ACMR's Debt to Equity ratio of 0.22 is in line compared to the rest of the industry. ACMR outperforms 45.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC0.74
WACC11.25%
ACMR Yearly LT Debt VS Equity VS FCFACMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACMR has a Current Ratio of 2.45. This indicates that ACMR is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.45, ACMR perfoms like the industry average, outperforming 40.18% of the companies in the same industry.
A Quick Ratio of 1.49 indicates that ACMR should not have too much problems paying its short term obligations.
ACMR has a worse Quick ratio (1.49) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.49
ACMR Yearly Current Assets VS Current LiabilitesACMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

6

3. Growth

3.1 Past

ACMR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
The Earnings Per Share has been growing by 42.35% on average over the past years. This is a very strong growth
Looking at the last year, ACMR shows a quite strong growth in Revenue. The Revenue has grown by 17.53% in the last year.
ACMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.72% yearly.
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
Revenue 1Y (TTM)17.53%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%

3.2 Future

Based on estimates for the next years, ACMR will show a small growth in Earnings Per Share. The EPS will grow by 1.96% on average per year.
The Revenue is expected to grow by 16.65% on average over the next years. This is quite good.
EPS Next Y-3.8%
EPS Next 2Y1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.34%
Revenue Next 2Y18.76%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACMR Yearly Revenue VS EstimatesACMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ACMR Yearly EPS VS EstimatesACMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ACMR is valuated rather expensively with a Price/Earnings ratio of 18.98.
Based on the Price/Earnings ratio, ACMR is valued cheaper than 86.61% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACMR to the average of the S&P500 Index (27.86), we can say ACMR is valued slightly cheaper.
The Price/Forward Earnings ratio is 17.69, which indicates a rather expensive current valuation of ACMR.
84.82% of the companies in the same industry are more expensive than ACMR, based on the Price/Forward Earnings ratio.
ACMR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.32.
Industry RankSector Rank
PE 18.98
Fwd PE 17.69
ACMR Price Earnings VS Forward Price EarningsACMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACMR indicates a rather cheap valuation: ACMR is cheaper than 80.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.55
ACMR Per share dataACMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The decent profitability rating of ACMR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.45
EPS Next 2Y1.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACMR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (10/3/2025, 8:20:47 PM)

After market: 41.25 -0.31 (-0.75%)

41.56

-1.76 (-4.06%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners70.05%
Inst Owner Change2.64%
Ins Owners5.53%
Ins Owner Change0%
Market Cap2.65B
Analysts81.43
Price Target38.01 (-8.54%)
Short Float %8.59%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.05%
Min EPS beat(2)5.36%
Max EPS beat(2)22.75%
EPS beat(4)4
Avg EPS beat(4)33.95%
Min EPS beat(4)5.36%
Max EPS beat(4)65.81%
EPS beat(8)8
Avg EPS beat(8)56.84%
EPS beat(12)12
Avg EPS beat(12)939.34%
EPS beat(16)15
Avg EPS beat(16)715.5%
Revenue beat(2)1
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-5.49%
Max Revenue beat(2)2.19%
Revenue beat(4)3
Avg Revenue beat(4)3.43%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)12.4%
Revenue beat(8)6
Avg Revenue beat(8)5.81%
Revenue beat(12)10
Avg Revenue beat(12)7.93%
Revenue beat(16)12
Avg Revenue beat(16)7.41%
PT rev (1m)2.25%
PT rev (3m)3.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE 17.69
P/S 3.26
P/FCF N/A
P/OCF 43.63
P/B 2.69
P/tB 2.7
EV/EBITDA 15.55
EPS(TTM)2.19
EY5.27%
EPS(NY)2.35
Fwd EY5.65%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.95
OCFY2.29%
SpS12.76
BVpS15.45
TBVpS15.4
PEG (NY)N/A
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 11.37%
ROCE 10.64%
ROIC 8.31%
ROICexc 12.74%
ROICexgc 12.78%
OM 17.87%
PM (TTM) 13.75%
GM 49.4%
FCFM N/A
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ROICexc(3y)11.47%
ROICexc(5y)11.39%
ROICexgc(3y)11.51%
ROICexgc(5y)11.42%
ROCE(3y)9.71%
ROCE(5y)8.55%
ROICexcg growth 3Y8.64%
ROICexcg growth 5Y4.84%
ROICexc growth 3Y8.55%
ROICexc growth 5Y4.8%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr 671.56%
Cap/Sales 9.59%
Interest Coverage 25.35
Cash Conversion 38.68%
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 1.49
Altman-Z 3.02
F-Score4
WACC11.25%
ROIC/WACC0.74
Cap/Depr(3y)1126.77%
Cap/Depr(5y)1047%
Cap/Sales(3y)15.44%
Cap/Sales(5y)11.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
EPS Next Y-3.8%
EPS Next 2Y1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.53%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%
Revenue Next Year21.34%
Revenue Next 2Y18.76%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%
EBIT growth 1Y21.83%
EBIT growth 3Y57.43%
EBIT growth 5Y53.36%
EBIT Next Year-2.09%
EBIT Next 3Y13.48%
EBIT Next 5Y11.92%
FCF growth 1Y87.13%
FCF growth 3YN/A
FCF growth 5Y51.73%
OCF growth 1Y342.07%
OCF growth 3YN/A
OCF growth 5Y74.58%